ライフサイエンスコーパス: vaginosis

1 is (one of the causative agents of bacterial vaginosis).

2 obiota, 4-6 intermediate, and 7-10 bacterial vaginosis).

3 ew treatments to prevent recurrent bacterial vaginosis.

4 ally transmitted infections during bacterial vaginosis.

5 ial agent used in the treatment of bacterial vaginosis.

6 nt scores but not among women with bacterial vaginosis.

7 dnerella vaginalis predominates in bacterial vaginosis.

8 ompared with women with no STIs or bacterial vaginosis.

9 play a role in the pathogenesis of bacterial vaginosis.

10 d as a factor for the diagnosis of bacterial vaginosis.

11 o vaginal symptoms associated with bacterial vaginosis.

12 40.2% were classified as involving bacterial vaginosis.

13 in women who are asymptomatic for bacterial vaginosis.

14 s before enrollment, 131 (39%) had bacterial vaginosis.

15 ng asymptomatic pregnant women for bacterial vaginosis.

16 -risk pregnancies for asymptomatic bacterial vaginosis.

17 gical constituents responsible for bacterial vaginosis.

18 sociated with an increased risk of bacterial vaginosis.

19 cytokine expression in response to bacterial vaginosis.

20 in-V) to prevent the recurrence of bacterial vaginosis.

21 cing lactobacilli among women with bacterial vaginosis.

22 rder that were highly specific for bacterial vaginosis.

23 sease acquisition among women with bacterial vaginosis.

24 males, incident trichomoniasis and bacterial vaginosis.

25 s a probiotic for the treatment of bacterial vaginosis.

26 initis, Trichomonas vaginitis, and bacterial vaginosis.

27 -9 use on vaginal lactobacilli and bacterial vaginosis.

28 ing studies on the pathogenesis of bacterial vaginosis.

29 iciency virus (HIV), and 21.4% had Bacterial vaginosis.

30 elevated genital inflammation and bacterial vaginosis.

31 ers, for the pH-based diagnosis of bacterial vaginosis.

32 with presumed bacterial agents of Bacterial vaginosis.

33 egnant persons without symptoms of bacterial vaginosis.

34 ian cancer (4 studies; n = 26432), bacterial vaginosis (2 studies; n = 930), trichomoniasis (1 study;

35 lis, 17.8% (12.4%-23.1%; n = 822), bacterial vaginosis, 37.6% (18.0%-57.2%; n = 1208), peripheral mal

36 is, 29.1% (20.9%-37.2%; n = 5502), bacterial vaginosis, 50.8% (43.3%-58.4%; n = 4280), peripheral mal

37 Bacterial vaginosis, a common disorder among young women, is assoc

38 ukin-8 (IL-8) was not increased in bacterial vaginosis, accounting for low concentrations of neutroph

39 Bacterial vaginosis affects 15 to 50% of women of reproductive age

40 Bacterial vaginosis affects millions of women and is associated wi

41 Bacterial vaginosis affects one third of reproductive-aged women,

42 Women with bacterial vaginosis alone or with concurrent Candida spp infection

43 The prevalence of bacterial vaginosis among lesbians is high.

44 In the US, reported prevalence of bacterial vaginosis among pregnant women ranges from 5.8% to 19.3%

45 es analyzed, 10 from patients with bacterial vaginosis and 10 from patients without bacterial vaginos

46 aginal fluid from 27 subjects with bacterial vaginosis and 46 without the condition.

47 ed, since prevention strategies of bacterial vaginosis and colonization by certain biotypes of G. vag

48 ciated with M. genitalium, whereas bacterial vaginosis and cunnilingus were negatively associated.

49 other black (ACB) women, including bacterial vaginosis and herpes simplex virus type-2 (HSV-2) infect

50 an women with a high prevalence of bacterial vaginosis and high adherence to PrEP, the efficacy of da

51 antimicrobial polypeptides in both bacterial vaginosis and in vulvovaginal candidiasis, suggesting th

52 d no association between confirmed bacterial vaginosis and MHM (OR: 1.07, 95% CI: 0.52-2.24).

53 for polymicrobial diseases such as bacterial vaginosis and periodontal disease.

54 gic findings identified women with bacterial vaginosis and revealed that cytolysis of vaginal epithel

55 ctions, but much higher numbers of bacterial vaginosis and vulvovaginal candidiasis infections.

56 rizes our current understanding of bacterial vaginosis and where future research should be focused.

57 ge who had received a diagnosis of bacterial vaginosis and who had completed a course of vaginal metr

58 and 99 nonpregnant women, all with bacterial vaginosis and without concurrent sexually transmitted in

59 , 16.1% for T vaginalis, 18.1% for bacterial vaginosis, and 8.6% for vulvovaginal candidiasis.

60 , Trichomonas vaginalis infection, bacterial vaginosis, and incident syphilis infection.

61 educes HPV, genital ulcer disease, bacterial vaginosis, and trichomoniasis among female partners.

62 s, vaginal discharge, candidiasis, bacterial vaginosis, and trichomoniasis.

63 nsmitter (i.e., male circumcision, bacterial vaginosis, and use of acyclovir) explained 46% of variat

64 lly diagnosed vaginal candidiasis, bacterial vaginosis, and vaginal trichomoniasis using some combina

65 matis, N gonorrhoeae, T vaginalis, bacterial vaginosis, and vulvovaginal candidiasis were the gold st

66 er excluding women with concurrent bacterial vaginosis, another possible cause of vaginal symptoms, t

67 Abnormal vaginal flora and bacterial vaginosis are associated with amplified risks of late mi

68 recommended treatment options for bacterial vaginosis are associated with high rates of recurrence.

69 ks and 2) body mass index <19.8 or bacterial vaginosis as assessed by Gram stain.

70 l population who have asymptomatic bacterial vaginosis (as diagnosed on the basis of vaginal Gram's s

71 ent co-occurrence of Mycoplasma and bacteria vaginosis associated bacteria 3 (BVAB3) among black and

72 est evidence to date for a risk of bacterial vaginosis associated with douching.

73 Resistance to clindamycin by bacterial vaginosis-associated anaerobic organisms has also been d

74 The role of newly defined bacterial vaginosis-associated bacteria (BVAB), which have a speci

75 ng regarding the potential role of bacterial vaginosis-associated bacteria in urethritis, although re

76 cillus iners or a diverse array of bacterial vaginosis-associated bacteria including Gardnerella vagi

77 by colonization with commensal and bacterial vaginosis-associated bacteria.

78 evels of Lactobacillus relative to bacterial vaginosis-associated bacteria.

79 including increased frequencies of bacterial vaginosis-associated bacterium 1 [BVAB1], BVAB2, BVAB3,

80 vaginosis (BV)--Atopobium vaginae, Bacterial Vaginosis-Associated Bacterium 2 (BVAB-2), Gardnerella v

81 the presence and concentration of bacterial vaginosis-associated microbes and commensal Lactobacillu

82 edian age 33 years), 357 (24%) had bacterial vaginosis at enrolment.

83 prevalent bacteria associated with bacterial vaginosis (Atopobium vaginae and Prevotella bivia).

84 andida, gastrointestinal- system, vaginitis, vaginosis-bacterial, and related terms.

85 highly prevalent in subjects with bacterial vaginosis but rare in healthy controls.

86 Bacterial vaginosis (BV) affects almost a quarter of US women, mak

87 amples from women with and without bacterial vaginosis (BV) and a human 3-dimensional cervical epithe

88 a significant association between bacterial vaginosis (BV) and acquisition of sexually transmitted d

89 ecular assays for the diagnosis of bacterial vaginosis (BV) and examined the impact of an incremental

90 sed the association between recent bacterial vaginosis (BV) and incident Mycoplasma genitalium, a sex

91 bacterial species associated with bacterial vaginosis (BV) and its significant adverse sequelae, inc

92 surrounds the association between bacterial vaginosis (BV) and pelvic inflammatory disease (PID).

93 Bacterial vaginosis (BV) and vaginal candidiasis are prominent cau

94 Bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC) presen

95 ted in vaginal infections, notably bacterial vaginosis (BV) and vulvovaginal candidiasis (VVC), parti

96 Both factors are modulated by bacterial vaginosis (BV) and, to some extent, by Lactobacillus ine

97 ses for the presence or absence of bacterial vaginosis (BV) and/or symptomatic vulvovaginal candidias

98 ce, sexual behavior, and suspected bacterial vaginosis (BV) as defined by Nugent Gram stain score >/=

99 cribed as normal, intermediate, or bacterial vaginosis (BV) as defined by Nugent's criteria.

100 to assess the relationship between bacterial vaginosis (BV) assessed by Gram stain and incident trich

101 thogenesis and transmissibility of bacterial vaginosis (BV) because it can be diagnosed in both membe

102 microbes isolated from women with bacterial vaginosis (BV) before and after therapy, 119 nonpregnant

103 ave been detected in subjects with bacterial vaginosis (BV) by using broad-range PCR assays, but this

104 Bacterial vaginosis (BV) can cause vaginal dysbiosis that may infl

105 Bacterial vaginosis (BV) causes genital inflammation and increased

106 BackgroundBacterial vaginosis (BV) causes genital inflammation and increases

107 women have a higher prevalence of bacterial vaginosis (BV) compared to HSV-2-seronegative women.

108 Women with bacterial vaginosis (BV) display reduced vaginal acidity, which ma

109 Women with bacterial vaginosis (BV) have complex communities of anaerobic bac

110 ly transmitted diseases (STDs) and bacterial vaginosis (BV) have increased rates of cytomegalovirus (

111 Bacterial vaginosis (BV) in pregnancy is linked to preterm birth,

112 Bacterial vaginosis (BV) is a clinical syndrome presenting with a

113 Bacterial vaginosis (BV) is a common cause of vaginal discharge an

114 Bacterial vaginosis (BV) is a common cause of vaginal infection.

115 Bacterial vaginosis (BV) is a common clinical syndrome in which th

116 Bacterial vaginosis (BV) is a common condition among women of repr

117 Bacterial vaginosis (BV) is a common condition characterized by a

118 Bacterial vaginosis (BV) is a common disorder characterized by inc

119 Bacterial vaginosis (BV) is a common polymicrobial disease associa

120 Bacterial vaginosis (BV) is a common polymicrobial imbalance of th

121 Bacterial vaginosis (BV) is a common vaginal dysbiosis that often

122 Bacterial vaginosis (BV) is a condition associated with adverse he

123 Bacterial vaginosis (BV) is a condition marked by high vaginal bac

124 Bacterial vaginosis (BV) is a dysbiotic condition of the vaginal m

125 Bacterial vaginosis (BV) is a genital infection that frequently pr

126 Bacterial vaginosis (BV) is a highly prevalent condition that is a

127 Bacterial vaginosis (BV) is a major health problem associated with

128 Bacterial vaginosis (BV) is a perturbation of vaginal flora charac

129 Bacterial vaginosis (BV) is a polymicrobial imbalance of the vagin

130 Bacterial vaginosis (BV) is a vaginal microbiome disorder that is

131 Bacterial vaginosis (BV) is a well-known risk factor for preterm b

132 Bacterial vaginosis (BV) is associated with an increased rate of s

133 Bacterial vaginosis (BV) is associated with complications of pregn

134 Bacterial vaginosis (BV) is associated with HIV acquisition and ad

135 Bacterial vaginosis (BV) is associated with human immunodeficiency

136 Bacterial vaginosis (BV) is associated with increased risk of obst

137 Bacterial vaginosis (BV) is caused by the excessive and imbalanced

138 Bacterial vaginosis (BV) is characterized by dramatic changes in t

139 Bacterial vaginosis (BV) is characterized by low abundance of Lact

140 Bacterial vaginosis (BV) is characterized by low levels of lactoba

141 Bacterial vaginosis (BV) is difficult to eradicate due to BV biofi

142 ndard" method for the diagnosis of bacterial vaginosis (BV) is lacking.

143 Bacterial vaginosis (BV) is one of the most common causes of vagin

144 Bacterial vaginosis (BV) is the most common cause of vaginal disch

145 Bacterial vaginosis (BV) is the most common cause of vaginal disch

146 Bacterial vaginosis (BV) is the most common cause of vaginal disch

147 Bacterial vaginosis (BV) is the most common gynecological infectio

148 Bacterial vaginosis (BV) is the most common vaginal infection in r

149 Bacterial vaginosis (BV) is the most prevalent vaginal condition a

150 Bacterial vaginosis (BV) is the worldwide leading vaginal disorder

151 Bacterial vaginosis (BV) may be common among women who report havi

152 c vaginal bacteria associated with bacterial vaginosis (BV) may increase the risk of adverse health o

153 Bacterial vaginosis (BV) may increase women's susceptibility to se

154 rus (HPV) infection is affected by bacterial vaginosis (BV) or Trichomonas vaginalis (TV) infection h

155 Bacterial vaginosis (BV) recurrence posttreatment is common.

156 test were compared with a unified bacterial-vaginosis (BV) reference standard incorporating both Nug

157 Bacterial vaginosis (BV) represents shifts in microbiota from Lact

158 bacteria have been associated with bacterial vaginosis (BV) using broad-range bacterial PCR methods s

159 t anaerobe, Atopobium vaginae, and bacterial vaginosis (BV) warrants further investigation.

160 Bacterial vaginosis (BV) was diagnosed by Nugent score, and cervic

161 sma hominis, and Candida albicans; bacterial vaginosis (BV) was identified by clinical criteria.

162 Bacterial vaginosis (BV) was identified recently as a cofactor tha

163 -year follow-up, 50 women acquired bacterial vaginosis (BV), 25 acquired symptomatic vulvovaginal can

164 Bacterial vaginosis (BV), a common syndrome characterized by Lacto

165 rdnerella vaginalis is abundant in bacterial vaginosis (BV), a condition associated with adverse repr

166 votal player in the progression of bacterial vaginosis (BV), a condition associated with serious heal

167 Bacterial vaginosis (BV), a disorder of the female reproductive tr

168 Bacterial vaginosis (BV), a disruption of the normal vaginal flora

169 Women with bacterial vaginosis (BV), an imbalance of the vaginal microbiome,

170 al colonization with lactobacilli, bacterial vaginosis (BV), and acquisition of human immunodeficienc

171 rformed to determine the burden of bacterial vaginosis (BV), and behavioral factors influencing the v

172 ifetime sexual partners, syphilis, bacterial vaginosis (BV), and vaginal candidiasis.

173 Bacterial vaginosis (BV), characterized by an imbalance in the vag

174 enii vaginally and/or rectally had bacterial vaginosis (BV), compared with 12 (44%) of 27 females col

175 espite the worldwide prevalence of bacterial vaginosis (BV), its etiology is still unknown.

176 itis commonly occurs in women with bacterial vaginosis (BV), often without concomitant chlamydial or

177 Bacterial vaginosis (BV), primarily attributed to Gardnerella vagi

178 requently isolated from women with bacterial vaginosis (BV), produces a cholesterol-dependent cytolys

179 Following all forms of therapy for bacterial vaginosis (BV), recurrence rates are extremely high.

180 e expert technical consultation on bacterial vaginosis (BV), sponsored by the National Institute of A

181 Bacterial vaginosis (BV), the overgrowth of diverse anaerobic bact

182 During bacterial vaginosis (BV), there is a loss of vaginal acidity, and

183 The primary end points were bacterial vaginosis (BV), vaginal candidiasis, trichomoniasis vagi

184 Infectious vaginitis due to bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and Tric

185 symptoms are common, diagnosis of bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), and Tric

186 more vaginal infections, including bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), or Trich

187 roscopy and limited to testing for bacterial vaginosis (BV), vulvovaginal candidiasis, and trichomoni

188 experts technical consultation on bacterial vaginosis (BV), where data regarding controversies over

189 ve indicators for the diagnosis of bacterial vaginosis (BV)--Atopobium vaginae, Bacterial Vaginosis-A

190 years, 10.9% with HIV, 21.4% with Bacterial vaginosis (BV).

191 ive (HIV(-)) women with or without bacterial vaginosis (BV).

192 detected in women with and without bacterial vaginosis (BV).

193 an important etiological agent in bacterial vaginosis (BV).

194 terations induced by pregnancy and bacterial vaginosis (BV).

195 tic approaches to the treatment of bacterial vaginosis (BV).

196 s the most common species found in bacterial vaginosis (BV).

197 enital inflammation and persistent bacterial vaginosis (BV); this subtype could be predicted with hig

198 r recurrent genital herpes, having bacterial vaginosis by Nugent criteria, and having had two or more

199 to-treat population, recurrence of bacterial vaginosis by week 12 occurred in 46 participants (30%) i

200 e of women who had a recurrence of bacterial vaginosis by week 12.

201 %) but a low specificity (zero for bacterial vaginosis, candida, and Trichomonas vaginalis).

202 Samples for detection of bacterial vaginosis, Chlamydia trachomatis, and Neisseria gonorrho

203 is enhanced in pregnant women with bacterial vaginosis, compared with that in nonpregnant women.

204 Bacterial vaginosis during pregnancy has been associated with adve

205 l differences persist for rates of bacterial vaginosis even when other known risk factors are control

206 nd why some but not all women with bacterial vaginosis experience complications.

207 PCR was used to survey bacterial vaginosis flora before and after metronidazole treatment

208 Bacterial vaginosis frequently persists after treatment.

209 s are available that differentiate bacterial vaginosis from other types of vaginal disorders, but non

210 entrations, menstrual cycle phase, bacterial vaginosis, genital bleeding, or plasma virus detection.

211 -up prevalences of trichomoniasis, bacterial vaginosis, gonorrhoea, and chlamydia infection were sign

212 Among women with bacterial vaginosis, H(2)O(2)-producing lactobacillus colonization

213 Women without bacterial vaginosis had 1 to 6 vaginal bacterial species (phylotyp

214 Women with bacterial vaginosis had greater bacterial diversity (P<0.001), wit

215 While bacterial vaginosis has been associated with an increased risk of

216 Bacterial vaginosis has been associated with preterm birth.

217 int-of-care diagnostic testing for bacterial vaginosis has emerged.

218 Women with bacterial vaginosis have complex vaginal infections with many newl

219 Women with bacterial vaginosis have different microbiological profiles.

220 .72% [95% CI -66.59 to 91.66]), or bacterial vaginosis (HIV incidence 0.9 per 100 person-years in the

221 ual physical examination findings (bacterial vaginosis, homogeneous discharge: sensitivity range, 69%

222 ne chlamydial infection (HR, 5.2), bacterial vaginosis (HR, 2.1), and the occurrence of genital ulcer

223 formance of vaginal pH testing for bacterial vaginosis improved by increasing the cutoff to 5.5, foll

224 the accurate at-home diagnosis of bacterial vaginosis, improving the capabilities of current low-cos

225 es from treatment for asymptomatic bacterial vaginosis in a general obstetric population but was inco

226 een reported to be associated with bacterial vaginosis in observational studies.

227 preterm birth by the treatment of bacterial vaginosis in pregnancy are disappointing.

228 enefits and harms of screening for bacterial vaginosis in pregnancy by identifying new evidence addre

229 F) recommendation on screening for bacterial vaginosis in pregnancy.

230 enefits and harms of screening for bacterial vaginosis in pregnant persons at increased risk for pret

231 ty that screening for asymptomatic bacterial vaginosis in pregnant persons not at increased risk for

232 F recommends against screening for bacterial vaginosis in pregnant persons not at increased risk for

233 enefits and harms of screening for bacterial vaginosis in pregnant women at high risk for preterm del

234 Do not screen for bacterial vaginosis in pregnant women at low risk for preterm deli

235 The treatment of asymptomatic bacterial vaginosis in pregnant women does not reduce the occurren

236 clinical trials, the treatment of bacterial vaginosis in pregnant women who previously had a preterm

237 ion, vulvovaginal candidiasis, and bacterial vaginosis) in HIV-1-seropositive versus HIV-1-seronegati

238 diagnose abnormal vaginal flora or bacterial vaginosis, in accordance with Nugent's criteria.

239 ylotypes and those associated with bacterial vaginosis, including Atopobium vaginae, were identified

240 es were detected in the women with bacterial vaginosis, including several species with no close culti

241 Bacterial vaginosis increases the susceptibility to sexually trans

242 Bacterial vaginosis is a common condition associated with increase

243 Bacterial vaginosis is a condition associated with adverse reprodu

244 Bacterial vaginosis is a highly prevalent and poorly understood po

245 Bacterial vaginosis is a risk factor for preterm birth.

246 Persistent bacterial vaginosis is associated with several bacteria in the Clo

247 Bacterial vaginosis is common and is caused by a disruption of the

248 ginal lavage fluid from women with bacterial vaginosis is deficient in antimicrobial polypeptides and

249 Bacterial vaginosis is far more than a nuisance infection.

250 Bacterial vaginosis is the most common lower genital tract syndrom

251 Bacterial vaginosis is the most common vaginal condition and is va

252 Bacterial vaginosis is the most common vaginal disorder in women,

253 normal immunostimulatory flora in bacterial vaginosis is thus associated with a local deficiency of

254 x only with men, or to women whose bacterial vaginosis is treated with oral antibiotics.

255 The etiology of bacterial vaginosis is unknown, and there are no long-term therapi

256 Bacterial vaginosis leaves patients with undesirable vaginal disch

257 or on examination is predictive of bacterial vaginosis (LR, 3.2 [95% CI, 2.1-4.7]) while lack of odor

258 outcomes; identifying and treating bacterial vaginosis may reduce its occurrence.

259 Bacterial vaginosis might increase HIV risk by eliciting genital i

260 We investigated whether bacterial vaginosis modified the efficacy of oral PrEP.

261 For bacterial vaginosis (n=73), neither the shedding of HIV-1 RNA (fro

262 nosis and 10 from patients without bacterial vaginosis, none shared the same DNA fingerprint.

263 Women (N = 40) with incident bacterial vaginosis (Nugent 7-10) had significantly lower concentr

264 , the Osmetech Microbial Analyzer--Bacterial Vaginosis (OMA-BV), which determines a patient's BV stat

265 ' gestation (mean 15.6 weeks)--for bacterial vaginosis or abnormal vaginal flora.

266 ore labor for risk factors such as bacterial vaginosis or during preterm labor have not consistently

267 he need for concurrent testing for bacterial vaginosis or vaginal dysbiosis.

268 e (P=.008), and lower frequency of bacterial vaginosis (P<.001) and gonorrhea (P=.03).

269 e whether prevention or control of bacterial vaginosis, particularly approaches that rely not on anti

270 eta-defensin-2 mRNA, but a typical bacterial vaginosis pathogen, Gardnerella vaginalis, had no effect

271 The cause of bacterial vaginosis remains poorly understood despite numerous stu

272 Bacterial vaginosis represents a unique upheaval of the complex va

273 Bacterial vaginosis resolved in 657 of 845 women who had follow-up

274 aginal sex (P = .04) and increased bacterial vaginosis risk (odds ratio, 4.2; 95% confidence interval

275 e the causal effect of douching on bacterial vaginosis risk while controlling for this confounding ef

276 2 weeks reduced the likelihood of bacterial vaginosis (RR, 0.5; 95% CI, 0.3-1.0).

277 sitivity 60.4%, specificity 45.6%; bacterial vaginosis sensitivity 61.6%, specificity 46.0%; and vulv

278 ensitivity but low specificity for bacterial vaginosis (sensitivity 95.2%, specificity 41.2%), and mo

279 mong subgroups of women defined by bacterial vaginosis status based on yearly microscopy and Nugent s

280 rhoeae, Trichomonas vaginalis, and bacterial vaginosis testing were collected from female adolescents

281 y lower incidence of recurrence of bacterial vaginosis than placebo at 12 weeks.

282 nonantibiotic adjunct to existing bacterial vaginosis therapies in order to decrease the risk of chr

283 l, and to explore the relevance of bacterial vaginosis to other adverse pregnancy outcomes, such as d

284 idelines for gonorrhea, chlamydia, bacterial vaginosis, trichomonas, vulvovaginal candidiasis, pelvic

285 Each diagnostic accuracy study for bacterial vaginosis, trichomoniasis, and genital herpes was perfor

286 ) and lack of perceived odor makes bacterial vaginosis unlikely (LR, 0.07 [95% CI, 0.01-0.51]).

287 sseria gonorrhoeae using NAATs and bacterial vaginosis using Gram stains.

288 ipants had point-of-care tests for bacterial vaginosis (vaginal pH of 5.0 or above) and Trichomonas v

289 Accuracy of screening tests for bacterial vaginosis varies.

290 ow-up, the incidence of persistent bacterial vaginosis was 26% and was statistically significantly hi

291 Bacterial vaginosis was assessed by Nugent score (Nugent-BV) and b

292 Bacterial vaginosis was associated with fewer episodes of VVC (adj

293 Bacterial vaginosis was based on a Nugent's Gram stain score of 7

294 Bacterial vaginosis was treated with intravaginal metronidazole ge

295 ng vaginal samples from women with bacterial vaginosis, we sequenced 16S genes using the V1-V3, V3-V4

296 rized as normal, intermediate, and bacterial vaginosis were included.

297 m, or vagina (including women with bacterial vaginosis), were obtained from BEI and ATCC resources.

298 is integral to the pathogenesis of bacterial vaginosis, which has substantial implications for the de

299 pective analysis of 947 women with bacterial vaginosis who were enrolled in prospective studies inves

300 tomatic abnormal vaginal flora and bacterial vaginosis with oral clindamycin early in the second trim